Flow Chemistry (CDMO)

Flow Chemistry (CDMO)
Product Description

PharmaResources provides advanced flow chemistry solutions to improve reaction safety, efficiency, and scalability in pharmaceutical development and manufacturing. Our capabilities cover continuous flow reactions, photochemistry, metal-mediated reactions, high-pressure reactions, and challenging transformations under extreme conditions. By integrating flow technology with process chemistry expertise, we enable better reaction control, improved yield, reduced impurities, and shorter cycle times. Our platform supports process optimization, scale-up, and technology transfer from laboratory development to GMP manufacturing.

PharmaResources (Kaiyuan) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Laboratory Services

PharmaResources (Kaiyuan) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Laboratory Services

More Products from PharmaResources (Kaiyuan) Co., Ltd. (9)

  • L-Carnitine

    Product L-Carnitine

    CAS NO.:541-15-1 USDMF CEP
  • Peramivir trihydrate

    Product Peramivir trihydrate

    CAS NO.: 1041434-82-5 DMF
  • Ticagrelor

    Product Ticagrelor

    CAS NO.: 274693-27-5 USDMF CEP GMP
  • Ticagrelor Intermediates

    Product Ticagrelor Intermediates

    CAS NO.: 376608-65-0 CAS NO.: 145783-15-9 CAS NO.: 1156491-10-9 CAS NO.: 376608-71-8 CAS NO.: 145783-14-8 CAS NO.: 376608-74-1 CAS NO.: 155899-66-4
  • AI & Computational Drug Design

    Product AI & Computational Drug Design

    PharmaResources integrates artificial intelligence, computational chemistry, and expert medicinal chemistry knowledge to accelerate drug discovery and optimization. Our AI-driven platform supports molecule generation, structure-based and ligand-based design, virtual screening, ADMET prediction, and propert...
  • Drug Discovery and Screening

    Product Drug Discovery and Screening

    PharmaResources provides integrated drug discovery solutions combining medicinal chemistry, chemical biology, and advanced screening technologies. Our capabilities cover target validation, hit identification, lead optimization, SAR-based design, ADME/PK evaluation, and candidate optimization. With expertis...
  • High Potency API

    Product High Potency API

    PharmaResources provides integrated HPAPI development and manufacturing capabilities, supporting projects from early research to clinical and commercial supply. Our high-containment facilities are designed for the safe handling of highly potent compounds, with capabilities covering route scouting, process ...
  • Process Development

    Product Process Development

    PharmaResources provides comprehensive process development solutions from route scouting to commercial manufacturing. Our experienced R&D team supports retrosynthetic analysis, novel route design, reaction optimization, and process scale-up. Through systematic studies of reaction parameters, catalyst s...
  • Huperzine-A Intermediates

    Product Huperzine-A Intermediates

    CAS NO.: 185741-44-0 CAS NO.: 130518-34-2

PharmaResources (Kaiyuan) Co., Ltd. resources (4)

  • News PharmaResources Marketing-CADD Service

    Our Computer-aided Drug Design (CADD) team has standardized procedures and highly-skilled scientists for solving complex problems related to discovery. The CADD team routinely supports discovery projects starting from target identification to lead optimization. We can provide virtual screening, scaffold hopping and de-novo molecule design. We have a wide range of tools available for compound optimization. Also, we have proven expertise in collaborative small molecule, PROTAC and peptide drug discovery projects.
  • Brochure PharmaResources

    PharmaResources is a fast growing CRO/CDMO company based in China, which is a one-stop service provider of small molecules for new drug discovery and manufacturing. Currently we have around 1000 scientists, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.